Volume 148, Issue 1, Pages (July 2015)

Slides:



Advertisements
Similar presentations
The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease S. Karia, R. Mahadeva, A. Balan, J. Babar Clinical Radiology.
Advertisements

Volume 150, Issue 1, Pages (July 2016)
Volume 109, Issue 1, Pages (January 1996)
Instrumental Transatrial Mitral Valvotomy
Volume 32, Issue 1, Pages (July 1957)
Goldberg Linn , M.D., Elliot Diane L. , M.D., Kuehl Kerry S. , M.S. 
Pulmonary Tuberous Sclerosis
Volume 100, Issue 5, Pages (November 1991)
Colloquium on Therapy of Right Heart Failure
Assessment and Diagnosis of Renal Dysfunction in the ICU
Incidence and Outcomes of Asthma in the Elderly
Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke
Volume 146, Issue 5, Pages (November 2014)
Right-Sided Chest Pain with Progressive Dyspnea
Volume 56, Issue 1, Pages (July 1969)
Adrenal Response in Severe Community-Acquired Pneumonia
Causes of Pulmonary Hypertension in the Elderly
Epidemiology and Treatment of Lung Cancer in Seattle
Bovine Tuberculosis Eradication
Volume 105, Issue 3, Pages (March 1994)
Volume 144, Issue 1, Pages (July 2013)
Wan-Jie Gu, MSc, Chun-Yin Wei, MSc, Rui-Xing Yin, MD, PhD  CHEST 
Robert Pickering, M.D, Fernando J. Martinez, M.D  CHEST 
Volume 95, Issue 1, Pages (January 1989)
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Pulmonary Embolism as a Cause of Death in Patients With Heart Disease
Volume 147, Issue 6, Pages (June 2015)
Volume 127, Issue 6, Pages (June 2005)
Air Pollution and Chest Disease
Antibiotic Treatment of Exacerbations of COPD
Single-Breath Washout Tests to Assess Small Airway Disease in COPD
Clinical and Personality Profiles and Survival in Patients With COPD
Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia
Volume 148, Issue 5, Pages (November 2015)
Volume 104, Issue 1, Pages (July 1993)
Volume 142, Issue 1, Pages (July 2012)
Volume 151, Issue 3, Pages (March 2017)
Volume 140, Issue 2, Pages (August 2011)
Volume 115, Issue 2, Pages (February 1999)
COPD by the Guidelines.
Volume 153, Issue 4, Pages (April 2018)
Shireen Mirza, MBBS, Roberto Benzo, MD  Mayo Clinic Proceedings 
The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors  Andrea L. Cheville, MD, MSCE,
Volume 153, Issue 1, Pages (January 2018)
Observers in the Medical Setting
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Volume 152, Issue 6, Pages (December 2017)
Idiopathic Pulmonary Arterial Hypertension in Asians
Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP  CHEST 
Counterpoint: Should All ICU Patients Receive Continuous Sedation? No
Volume 146, Issue 5, Pages (November 2014)
Influences of Chronic Obstructive Pulmonary Disease on Outcomes of Total Arch Replacement  Shunsuke Miyahara, MD, Hidekazu Nakai, MD, Naoto Izawa, MD,
Volume 97, Issue 1, Pages (January 1990)
Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind,
Volume 155, Issue 1, Pages (January 2019)
Volume 155, Issue 1, Pages (January 2019)
Volume 154, Issue 6, Pages (December 2018)
Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients?  Filipa Tavares, MD  Journal of Pain and Symptom.
Volume 92, Issue 1, Pages (July 1987)
Bedside Calibration Of Pulmonary Artery Catheters
Invasive Pulmonary Aspergillosis
Pulmonary Manifestations in a Case of Multiple Myeloma
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Volume 42, Issue 2, Pages (August 1962)
Calcification of the Coronary Artery
New Members of the Editorial Board
John Reid, MD, Donald Cockcroft, MD  CHEST 
Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD scheme for classifying patients with COPD with separate appraisal of air-flow limitation.
Mott Frank E. , MD, Sharma Neeraj , MD, Ashley Pandora   CHEST 
Presentation transcript:

Volume 148, Issue 1, Pages 159-168 (July 2015) Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD  Ciro Casanova, MD, Jose M. Marin, MD, Cristina Martinez-Gonzalez, MD, Pilar de Lucas-Ramos, MD, Isabel Mir-Viladrich, MD, Borja Cosio, MD, German Peces-Barba, MD, Ingrid Solanes-García, MD, Ramón Agüero, MD, Nuria Feu-Collado, MD, Miryam Calle-Rubio, MD, Inmaculada Alfageme, MD, Alfredo de Diego-Damia, MD, Rosa Irigaray, MD, Margarita Marín, MD, Eva Balcells, MD, Antonia Llunell, MD, Juan Bautista Galdiz, MD, Rafael Golpe, MD, Celia Lacarcel, MD, Carlos Cabrera, MD, Alicia Marin, MD, Joan B. Soriano, MD, Jose Luis Lopez-Campos, MD, Juan José Soler-Cataluña, MD, Juan P. de-Torres, MD  CHEST  Volume 148, Issue 1, Pages 159-168 (July 2015) DOI: 10.1378/chest.14-2449 Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 1 Comparative type 2 receiver operating characteristic curves for the CAT, the CCQ, and the mMRC dyspnea score, with all-cause mortality as the main outcome in patients with COPD. CAT = COPD Assessment Test; CCQ = Clinical COPD Questionnaire; mMRC = modified Medical Research Council. CHEST 2015 148, 159-168DOI: (10.1378/chest.14-2449) Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 2 A-C, Kaplan-Meier curves for all-cause mortality using symptom-evaluating tools and cutoff proposed by GOLD (Global Initiative for Chronic Obstructive Lung Disease): A, CAT ≥ 10; B, CCQ > 1; C, mMRC dyspnea ≥ 2. The survival differed significantly between groups (P = .001) only when the mMRC dyspnea threshold was used. See Figure 1 legend for expansion of other abbreviations. CHEST 2015 148, 159-168DOI: (10.1378/chest.14-2449) Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 3 A, B, Kaplan-Meier curves for all-cause mortality using symptom-evaluating tools by GOLD with the new cutoff that have demonstrated to predict all-causes mortality: A, CAT ≥ 17; B, CCQ > 2.5. See Figure 1 and 2 legends for expansion of abbreviations. CHEST 2015 148, 159-168DOI: (10.1378/chest.14-2449) Copyright © 2015 The American College of Chest Physicians Terms and Conditions

Figure 4 A-C, Kaplan-Meier curves for all-cause mortality in the ABCD GOLD classification using symptom-evaluating tools with the new thresholds proposed in this study: A, CAT ≥ 17; B, CCQ > 2.5; C, mMRC dyspnea ≥ 2. See Figure 1 and 2 legends for expansion of abbreviations. CHEST 2015 148, 159-168DOI: (10.1378/chest.14-2449) Copyright © 2015 The American College of Chest Physicians Terms and Conditions